-
Cancer Gene Therapy Market Size to hit $19.97 Billion by 2033 | Key Drivers, Trends, Precision Oncology & FDA
30 Oct 2025 07:32 GMT
… In vivo Gene Therapy, Ex vivo Gene Therapy)
By Therapy … : (Brain Cancer, Lung Cancer, Breast Cancer, Pancreatic … gene-therapy-market
Challenges and Restraints
Despite remarkable progress, cancer gene therapy … as many gene therapies remain prohibitively …
-
Liver Complications Lead FDA to Stop Tests of Intellia Gene-Editing Therapy for a Rare Disease
02 Nov 2025 00:18 GMT
… of extensive-stage small cell lung cancer when used alongside the Roche … treatment for metastatic small cell lung cancer.
—The label of Johnson … indications.
—Vyjuvek, a Krystal Biotech gene therapy for the rare inherited skin …
-
One molecule could usher revolutionary medicines for cancer, diabetes and genetic disease — but the US is turning its back on it
01 Nov 2025 18:30 GMT
… researcher working on a lung cancer vaccine in the Ose … and non-small cell lung cancers.
Pancreatic cancer has historically … scientists developed a customized gene therapy consisting of a guide … patients access to personalized gene therapies like KJ's …
-
CAR T-Cell Therapy Market Size to Surpass USD 146.55 Billion by 2034 Fueled by Innovations in Cancer Treatment and Growing Demand for Personalized Therapies
30 Oct 2025 14:10 GMT
… tumors like glioblastoma and lung cancer. Overcoming tumor microenvironments … vivo CAR-T gene therapies can overcome the challenges … globally benchmarked cell and gene therapies to India, with a … Cancer
Ovarian Cancer
Lung Cancer
Prostate Cancer
Colorectal …
-
Nanomaterial-Driven Regulated Cell Death: Mechanistic Insights and Novel Strategies for Tumor Therapy
30 Oct 2025 11:46 GMT
… In non-small cell lung cancer, GSDMD downregulation inhibited … ATP7A, and ATP7B using gene therapy holds promise for cancer … NRF2 nano-modulator induces lung cancer ferroptosis and elicits … synergizes with immunotherapy in lung cancer. Sig Transduct Target …
-
Calidi Biotherapeutics Announces New Data to be Presented on its Therapeutic Lead, CLD-401, at the 2025 SITC Annual Meeting
30 Oct 2025 12:00 GMT
… IL-15 Superagonist via RedTail Gene Therapy Achieves Durable Tumor Clearance
Abstract … studies, targets non-small cell lung cancer, head and neck cancer, and …
-
United States Intratumoral Cancer Therapies Market Set for Robust Growth with Breakthrough Innovations by 2031
29 Oct 2025 12:25 GMT
… into chemotherapy, immunotherapy, gene therapy, and others. Among these … cancer, prostate cancer, lung cancer, and others. The … oncolytic viruses and gene therapies presents lucrative prospects … non-small cell lung cancer, highlighting regulatory progress …
-
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q3 2025 Earnings Call Transcript
29 Oct 2025 12:19 GMT
… cancers while building share in lung cancer. Earlier this month, … of Medicine, our novel gene therapy approach provided meaningful hearing gains … next 12 months. In lung cancer, Additionally, there has been … setting.
And now in lung cancer, Libtayo is now the …
-
IQVIA Holdings Inc. (NYSE:IQV) Q3 2025 Earnings Call Transcript
29 Oct 2025 12:19 GMT
… in African-American patients with lung cancer.
A biotech client selected IQVIA … our leadership in cell and gene therapy and cardiovascular research as well …
-
Hanmi Pharm Unveils Multiple Next‑Gen Cancer Drug Candidates at AACR‑NCI‑EORTC 2025
29 Oct 2025 09:03 GMT
… a monotherapy in colon and lung cancer animal models. A p53 mRNA … — including TPD, mRNA, cell & gene therapies (CGT), ADCs and single‑domain …